How many studies have been conducted on Interleukin 33?

BiohacksAI has indexed 300 PubMed studies on Interleukin 33, including 1 randomized controlled trials (RCTs). 32% of studies involve human subjects.

What are the main research areas for Interleukin 33?

The primary research domains for Interleukin 33 are 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Interleukin 33

A member of the INTERLEUKIN-1 protein family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 48.5

Research Domains

Interleukin 33 has been studied across 23 research domains including 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology, 🫁 Respiratory, 🦴 Bone & Joint. The primary research focus is 🔬 Inflammation with 97% of studies addressing this area.

Loading evidence profile...

This evidence profile for Interleukin 33 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.